VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar Wakester0 (58.46) Submitted: 8/8/2012 10:53:30 AM : Outperform Start Price: $22.40 VVUS Score: -9.12

Banking on the new weight-loss drug

Featured Broker Partners


Advertisement